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ABSTRACT Although it is well established that exocytosis of neurotransmitters and hormones is highly regulated by numerous
secretory proteins, such as SNARE proteins, there is an increasing appreciation of the importance of the chemophysical prop-
erties and organization of membrane lipids to various aspects of the exocytotic program. Based on amperometric recordings by
carbon ﬁber microelectrodes, we show that deprivation of membrane cholesterol by methyl-b-cyclodextrin not only inhibited the
extent of membrane depolarization-induced exocytosis, it also adversely affected the kinetics and quantal size of vesicle fusion in
neuroendocrine PC12 cells. In addition, total internal ﬂuorescence microscopy studies revealed that cholesterol depletion
impaired vesicle docking and trafﬁcking, which are believed to correlate with the dynamics of exocytosis. Furthermore, we found
that free cholesterol is able to directly trigger vesicle fusion, albeit with less potency and slower kinetics as compared to
membrane depolarization stimulation. These results underscore the versatile roles of cholesterol in facilitating exocytosis.INTRODUCTION
Intensive research in the past four decades has revealed that
the regulated secretion, or exocytosis, of neurotransmitters
and hormones is achieved through the temporally and
spatially coordinated actions of numerous secretory proteins
(1). Most notably, complexing between SNARE proteins,
involving VAMP on the vesicle and plasma membrane-asso-
ciated syntaxin and SNAP-25, is believed to be essential for
enabling membrane fusion (2). Although this classic protein-
centric view is well established, there is an increasing appre-
ciation of the importance of the chemophysical properties
and organization of membrane lipids to various aspects of
the exocytotic program (3–6). In particular, growing
evidence suggests that cholesterol, an abundant and essential
constituent of both plasma and vesicular membranes, is a crit-
ical regulator of exocytosis through collaboration with
protein factors (7–14).
It has been demonstrated in several cell types that choles-
terol acts as a prefusion organizer by stabilizing lipid
membrane microdomains or rafts, where secretory proteins,
particularly SNAREs, assemble to define vesicle docking
and fusion sites (9,15–17). Cholesterol may promote
membrane anchoring of the secretory proteins to fusion sites
via cholesterol-recognition elements on proteins (18).
Cholesterol deprivation disrupts cholesterol-enriched func-
tional microdomains and inhibits exocytosis in these cells.
Cholesterol is also an important factor in determining
membrane properties such as fluidity, rigidity, and curvature
(13,19,20). Modulation of cholesterol content in the plasma
membrane changes the energy barrier for coalescence
between two lipid bilayers and consequently alters the
vesicle fusion kinetics (21). Furthermore, cholesterol may
Submitted February 16, 2009, and accepted for publication June 22, 2009.
Jing Zhang and Renhao Xue contributed equally to this work.
*Correspondence: chenpeng@ntu.edu.sg
Editor: Joshua Zimmerberg.
 2009 by the Biophysical Society
0006-3495/09/09/1371/10 $2.00exert its influence on exocytosis indirectly by modulating
the actin cytoskeleton (22,23).
Based on amperometric recordings by carbon fiber micro-
electrodes, we show that deprivation of membrane choles-
terol by methyl-b-cyclodextrin (MbCD) not only inhibited
the extent of membrane depolarization-induced exocytosis,
it also adversely affected the kinetics and quantal size of
vesicle fusion in neuroendocrine PC12 cells. In addition,
total internal fluorescence microscopy (TIRFM) studies re-
vealed that cholesterol depletion impaired vesicle docking
and trafficking, which are believed to correlate with the
dynamics of exocytosis (24). Furthermore, we found that
free cholesterol is able to directly trigger vesicle fusion,
albeit with less potency and slower kinetics as compared to
membrane depolarization stimulation. These results under-
score the versatile roles played by cholesterol in facilitating
exocytosis.
MATERIALS AND METHODS
The materials and methods used in this study are described in the Supporting
Material.
RESULTS
The frequency of exocytotic events is reduced
by cholesterol depletion
MbCD sequesters cholesterol in its hydrophobic pocket (25)
and has been widely used to remove cholesterol from the
plasma membrane. To examine the effects of cholesterol
depletion on exocytosis, we compared high Kþ-triggered
exocytosis from the same cell before and after MbCD treat-
ment based on amperometric measurements. Amperometry,
in contrast to electrophysiological membrane capacitance
measurements (26,27), directly detects exocytosis with
single-vesicle resolution without interference by endocytosis.
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the details of the vesicle fusion kinetics catalyzed by fusion
proteins (28).
As shown in Fig. 1 A (top), superfusion of the cell with
high Kþ solution for 2 min by means of an application
pipette, which depolarizes the cell membrane, gave rise to
many amperometric current spikes as detected by the carbon
fiber microelectrode. Each current spike corresponds to the
release of catecholamine molecules from a single secretory
vesicle upon its fusion with the plasma membrane. In
comparison, the same cell responded to high Kþ stimulation
with a much-reduced number of amperometric signals after
incubation with 5 mM MbCD for 30 min (Fig. 1 A, middle).
The MbCD treatment removed 32.3% 5 2.8% (three cell
cultures; see Fig. S1 of the Supporting Material) of mem-
brane cholesterol, which is comparable to previous findings
FIGURE 1 Cholesterol depletion inhibits exocytosis. The amperometric
responses from two PC12 cells to high Kþ stimulation are shown in the
top row in A and B. The amperometric responses to the second high Kþ stim-
ulation from the same cells, with (A) or without (B) treatment with 5 mM
MbCD for 30 min, are displayed in the middle row. The average time
courses of the accumulative number of elicited amperometric spikes to the
first (gray) and second (solid) stimulations are shown in pairs for the two
protocols and are normalized to the average total spike number resulting
from the first stimulation (bottom row). These traces are averaged from
(A) 14 cells in which the average spike numbers in response to the first
and second stimulations after 30 min incubation of 5 mM MbCD are 49.95
7.5 and 19.9 5 4.4, respectively (p < 0.001); (B) 11 cells in which the
average spike numbers in response to the first and second stimulations after
30 min and without application of MbCD are 45.35 3.8 and 45.55 11.8,
respectively. The dashed curve in A is the response (26.05 5.1 events) from
the cells (n ¼ 17) whose membrane cholesterol was first depleted by 5 mM
MbCD and then reloaded by the application of 5 mM MbCD-cholesterol
complex; it is normalized to the average response to high Kþ stimulation
without any treatments. Replenishment of cholesterol provided only insig-
nificant exocytotic recovery (p > 0.05, dashed versus solid curve). The
dotted curve in A is the average response from 15 cells cultured in LPDS
medium (28.1 5 7.9 events) normalized by the average response from
15 cells cultured in FBS medium (56.1 5 6.5 events; p < 0.001 between
the two cell cultures).Biophysical Journal 97(5) 1371–1380(10). The average time courses of the exocytotic responses
(14 cells) to the first and second stimulations were normal-
ized to the average total number of spikes resulting from
the first high Kþ stimulation before 5 mM MbCD treatment
(Fig. 1 A, bottom). Exocytosis elicited by high Kþ stimula-
tion after cholesterol deprivation was reduced to 39.9% 5
16.0% of the normal response. This is consistent with the
results of a previous study, in which a statistical comparison
was performed between groups of control and MbCD-treated
cells (16). Cholesterol depletion also affected the kinetics of
exocytosis. The accumulative number of amperometric
spikes increased exponentially with a significantly slower
time constant (>140 s) in MbCD-treated cells compared to
controls (~40 s; Fig. 1 A, bottom).
Since the second stimulation was applied 30 min after the
first, however, it can be argued that the observed decrease in
the frequency of exocytotic events may be simply due to
deterioration of cells. This possibility was ruled out by
control experiments (11 cells), which showed that the paired
high Kþ stimulations, 30 min apart and without MbCD
application, elicited similar exocytotic responses (Fig. 1 B).
When MbCD is preloaded with cholesterol to saturation, it
can be used as a cholesterol donor to replenish cholesterol
in the cell membrane (12). Using this strategy, cholesterol
molecules carried by a 5 mM MbCD-cholesterol complex
were reloaded back into the cells after initial MbCD deple-
tion. After reloading was completed, the level of membrane
cholesterol was elevated to 167.6%5 25.4% of the normal
level without MbCD depletion (three cell cultures; Fig. S1),
similar to previously reported values (29). Despite the full
recovery of the membrane cholesterol level, however, the
rescue of MbCD-induced inhibition by cholesterol reloading
was insignificant (dashed curve in Fig. 1 A). This raises a
concern about the specificity of the MbCD treatment.
As an alternative strategy, cellular cholesterol was meta-
bolically deprived (30). Specifically, cells were cultured in
a medium supplemented with lipoprotein-deficient serum
(LPDS) in place of fetal bovine serum (FBS) 4–6 days before
the experiments to block cholesterol synthesis and deplete
cholesterol stores (31). In the LPDS-cultured cells, exocy-
totic responses triggered by high Kþ were significantly
reduced to ~50% of those in the FBS-cultured cells (Fig. 1 A,
bottom), similar to the consequence caused by MbCD. This
experiment corroborates the notion that cholesterol is crucial
in supporting exocytosis.
The rate and quantal size of vesicular release, and
prespike foot are reduced by cholesterol depletion
It is also evident from Fig. 1 that the amplitudes of the
amperometric events became generally smaller after deple-
tion of membrane cholesterol. This suggests that cholesterol
is involved in the process of quantal vesicle fusion. To inves-
tigate this phenomenon, individual amperometric signals in
the same experiments presented in Fig. 1 were extracted
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from the first and second stimulations are displayed in pairs
for the two different experimental protocols in Fig. 2 A. The
average amplitude of the amperometric spikes after choles-
terol depletion was decreased to 62.6% 5 4.6%. In line
with this, the rate of release, or the rate of fusion pore expan-
sion, which is quantified by the linear slope as the ampero-
metric spike rises from 35% to 90% of the peak amplitude,
is reduced to 56.0% 5 6.5% (Fig. 2 C). The quantal size
of vesicle release (Q), which is the total charge (integration)
of the amperometric current spike, was also reduced to
61.9% 5 3.9% by cholesterol depletion (Fig. 2 D). Again,
the control experiments confirmed that these observations
were not due to deterioration of cells. The average amplitude,
rise slope, and quantal size resulting from the second high
Kþ stimulation in the control cells were even slightly en-
hanced, possibly because of activity-dependent potentiation.
Replenishment of cholesterol in the cholesterol-depleted
cells completely rescued the reductions in amperometric
amplitude, fusion rate, and quantal size (Fig. 2, B–D), sug-
gesting that our observations were due to specific effects
of MbCD on cholesterol depletion. In addition, when choles-
terol was depleted by LPDS culturing, the rise slope and
quantal size also decreased to 29.4%5 2.1% and 71.7%5
3.1%, respectively (Fig. 2, B–D).A substantial energy barrier needs to be overcome to
enable fusion between the vesicular and plasma membranes.
When the driving force provided by fusion proteins barely
overcomes such an energy barrier, a small foot preceding
the amperometric spike occurs as a result of slow expansion
of the fusion pore (32). As shown in Fig. S5, cholesterol
depletion by MbCD or metabolic depletion reduced the
percentage of footed events and the foot size.
Vesicle fusion time is increased after
cholesterol depletion
In a previous study of rat chromaffin cells (33), it was sug-
gested that small and large vesicles may differ in terms of
the molecular machinery (i.e., the number and/or composi-
tion of proteins and/or lipids) required to drive fusion pore
expansion. For small vesicles, the halfwidth time of the
amperometric spike (t1/2), which indicates the duration of
vesicle fusion, linearly scales with the cubic root of the
quantal size (Q1/3), which reflects the vesicle size. For large
vesicles, t1/2 levels off at a plateau, meaning that large vesi-
cles dilate relatively more rapidly. It has been speculated that
additional fusion machines are accommodated in the fusion
complex of large vesicles and account for their expedited
fusion (33). As shown in Fig. 3 (open circles), a similar trendFIGURE 2 Cholesterol depletion impairs vesicle fusion.
Amperometric spikes obtained in the experiments pre-
sented in Fig. 1 were individually extracted and analyzed.
(A) The average spikes of the amperometric responses to
the first (gray) and second (solid) stimulations are shown
in pairs for the two protocols. The amplitudes for the two
paired spikes are normalized based on the average amper-
ometric amplitude responding to the first stimulation,
which is 17.31 5 0.69 pA (left, 5 mM MbCD protocol)
or 21.695 0.96 pA (right, control). (B) The average spike
from the cells replenished with cholesterol after initial
depletion is shown as the dashed trace on the left. Its ampli-
tude (20.03 5 1.14 pA, 17 cells) is normalized to the
amplitude of the gray trace shown in A (left). Average
spikes from cells cultured in FBS medium (gray, 16.405
0.66 pA) or LPDS medium (solid, 5.40 5 0.21 pA) are
shown in pairs on the right. (C) The statistics of the rise
slope of vesicle fusion defined by the linear slope between
35% and 90% of the peak amperometric amplitude. In the
5 mM MbCD protocol (the first paired columns on the left,
normalized to the response from the first stimulation), the
rise slopes are 10.10 5 0.62 pA/ms (blank) and 5.66 5
0.66 pA/ms (gray), from the first and second stimulations,
respectively. In the control experiments (the second paired
columns, normalized to the response from the first stimula-
tion), the rise slopes are 14.015 0.89 pA/ms (blank) and
16.255 1.00 pA/ms (gray), from the first and second stimulations, respectively. The rise slope after reloading of cholesterol (solid, normalized to the first
response in the MbCD protocol) is 9.635 0.80 pA/ms. Rise slopes from FBS-medium cultured cells (dotted gray, 10.545 0.61 pA/ms) and LPDS-medium
cultured cells (dotted, 3.105 0.22 pA/ms) are normalized and displayed in pairs on the right. (D) The statistics of the quantal size defined by the total charge
integration of the amperometric current spike. The data are normalized as described in C. In the 5 mM MbCD protocol (the first paired columns), the quantal
sizes are 64.225 2.01 fC (blank) and 39.765 2.51 fC (gray), from the first and second stimulations, respectively. In the control experiments (the second
paired columns), the quantal sizes are 60.345 2.28 fC (blank) and 74.885 2.19 fC (gray), from the first and second stimulations, respectively. The quantal
size after reloading of cholesterol (solid) is 74.75 5 2.78 fC. Quantal sizes from FBS-medium cultured cells (dotted gray, 74.14 5 2.20 fC) and LPDS-
medium cultured cells (dotted, 53.135 2.28 fC) are normalized and displayed in pairs on the right. **p < 0.01, ***p < 0.001.Biophysical Journal 97(5) 1371–1380
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fC1/3, t1/2 no longer increases linearly with Q
1/3, but instead
remains at ~3.2 ms. Of interest, the capping of t1/2 was
relieved by MbCD, i.e., a linear t1/2 and Q
1/3 relation resulted
(Fig. 3, gray circles). These data suggest that cholesterol is
critical for ensuring the quick release of large vesicles. More-
over, for a given vesicle size (Q1/3), the cholesterol-depleted
cells took a longer time to discharge their contents, and this
effect was more prominent for large vesicles. The MbCD-
induced slowdown in vesicle fusion is caused by depletion
of membrane cholesterol rather than nonspecific actions of
MbCD, because t1/2 and its saturation at large Q
1/3 were
recovered after the cholesterol-depleted cells were reloaded
with cholesterol (Fig. 3, solid circles). Metabolic depletion
of cholesterol by LPDS medium similarly impaired the fast
fusion of large vesicles, and increased the fusion time to an
even greater extent as compared to MbCD.
Exogenous cholesterol as secretagogue
Cholesterol not only makes exocytosis and vesicle fusion
more efficient, it can also directly stimulate exocytosis after
insertion into the exoplasmic leaflet of the plasma mem-
brane. As demonstrated in Fig. 4 A, amperometric signals ap-
peared after local superfusion with a cholesterol-containing
bath solution (2 mM diluted from 2 mM cholesterol-ethanol
stock) to cells via an application pipette. The vehicle control
(0.1% v/v ethanol in bath) was not able to elicit any response
(Fig. S4). The average increases in the accumulative spike
FIGURE 3 Relation between the halfwidth time of the amperometric
spike (t1/2) and the cubic root of quantal size (Q
1/3) is shown. These analyses
are based on the amperometric signals obtained from the same experiments
presented in Figs. 1 and 2. Each open circle represents the average of 80
vesicle fusion events in response to high Kþ stimulation without MbCD
treatment. These data points can be well fitted by an exponential (dashed
curve). Each solid gray circle represents the average of 20-vesicle fusion
in response to high Kþ stimulation after a 30-min treatment with 5 mM
MbCD. To indicate the trend, the gray circles are fitted by a line (gray
line). Each solid circle represents the average of 40-vesicle fusion from
the cells whose membrane cholesterol was reloaded after depletion. The
data is fitted by an exponential (solid curve).Biophysical Journal 97(5) 1371–1380number over time, in response to 2 min of cholesterol stim-
ulation (solid curve; 22 cells) and high Kþ stimulation in
parallel experiments (gray curve; 10 cells), are depicted in
Fig. 4 B. Notably, cholesterol stimulation is much less potent
than high Kþ stimulation.
The average amperometric signals from 272 cholesterol-
induced events and 474 high Kþ-induced events are plotted
in Fig. 4 C. Compared to that induced by high Kþ, choles-
terol-induced vesicle fusion manifested much slower
kinetics. Specifically, the rise slope of cholesterol-induced
fusion (3.47 5 0.59 pA/ms) was much smaller than that of
high Kþ-induced fusion (10.90 5 0.77 pA/ms), indicating
a slower rate of fusion pore expansion (Fig. 4 D). The
quantal size of cholesterol-induced fusion, however, is larger
than that of the high Kþ-induced fusion events (81.82 5
6.76 vs. 68.91 5 2.67 fC; Fig. 4 D). In the case of choles-
terol stimulation, the fusion pore opening (t1/2) is linearly
proportional to the vesicle size (Q1/3; Fig. 4 E), and for the
same vesicle size, cholesterol-induced vesicle fusion took a
much longer time (t1/2) to release as compared to high K
þ-
stimulated fusion. Insertion of exogenous cholesterol by
micropipette delivery of cholesterol-loaded MbCD also
induced similar amperometric responses with slow kinetics
(Fig. S6).
The ability of cholesterol to elicit vesicle fusion was
confirmed by total internal reflection fluorescence micros-
copy (TIRFM; Movie S1). With selective evanescent illumi-
nation of the thin section (~200 nm) just above the interface
between the glass coverslip and the adhered cell, TIRFM can
provide insights into dynamic events occurring at or close to
the plasma membrane of living cells, with outstanding
optical contrast and resolution. Subplasmalemmal secretory
vesicles in PC12 cells, specifically labeled by neuropeptide
Y conjugated with enhanced green fluorescent protein
(NPY-EGFP), were individually visualized and tracked at
0.5 s intervals with the use of TIRFM.
Fig. 5 A presents a pair of TIRFM images of a PC12 cell
immediately before (top) and 100 s after (bottom) the appli-
cation of 2 mM cholesterol to the bath solution. Vesicles in
the subplasmalemmal region can be clearly resolved. In
this experiment, the total number of the original subplasma-
lemmal vesicles was reduced from 19 to four in <2 min. In
the resting state, the total number of vesicles in the subplas-
malemmal region stayed constant (open circles in Fig. 5 B;
average from five cells). In contrast, after the application
of cholesterol, the total vesicle number decreased over time
(solid circles in Fig. 5 B; average from six cells). The
delivery rate of newly arrived vesicles (solid triangles in
Fig. 5 B) was enhanced in the presence of free cholesterol,
presumably to compensate for vesicle release.
Cholesterol depletion impairs vesicle trafﬁcking
and docking
Secretory vesicles undertake constant lateral movements in
the subplasmalemmal membrane region, where they explore,
Cholesterol to Exocytosis 1375FIGURE 4 Free cholesterol triggers exocytosis. (A)
Local application of 2 mM cholesterol to the cell for 1 min
elicited amperometric responses (left). A high Kþ triggered
amperometric recording in a parallel experiment on
a different cell is shown (right) for comparison. (B) The
average increase of accumulative spike number over time,
in response to cholesterol stimulation (solid curve; 22 cells)
or high Kþ stimulation (gray curve; 10 cells). (C) The
average amperometric spikes from cholesterol stimulation
(solid; 272 events) and high Kþ (gray; 474 events). (D)
The rise slope of cholesterol-induced vesicle fusion (solid
column on the left; 3.46 5 0.59 pA/ms) is smaller than
that of high Kþ-induced fusion (gray column on the left;
10.905 0.77 pA/ms), whereas the quantal size of choles-
terol-induced fusion (solid column on the right; 81.82 5
6.76 fC) is larger than that of high Kþ-induced fusion
(gray column on the right; 68.915 2.67 fC). (E) For choles-
terol-induced vesicle fusion, the halfwidth time of the
amperometric spike (t1/2) is linearly proportional to the
cubic root of the quantal size (Q1/3; gray circles fitted by
a line; each circle represents the average from 40 vesicles).
For a given Q1/3 (vesicle size), cholesterol-triggered fusion
takes longer to release compared to high Kþ-induced fusion
(open circles fitted by an exponential; same data set as
shown in Fig. 4). *p < 0.05, ***p < 0.001.interact with various proteins, and eventually are released at
exocytotic sites upon triggering. How vesicles move in the
near membrane region directly relates to the dynamics of
exocytosis (24). The lateral motion of individual vesicles
was tracked, at 0.5 s intervals for 2 min, from their appear-
ance at the beginning of imaging (for ‘‘predocked’’ vesicles)
or from their arrival to the subplasmalemmal region (for
newly arrived vesicles) until their retrieval back to the inner
cytosol. Fig. 6 A presents the trajectories of vesicle lateral
motion in a typical control (left) and an MbCD-treatedPC12 cell (right). An example trajectory from the control
cell is illustrated with an expanded scale (middle). From
this representative trace, and as demonstrated in our previous
study (34) and by others (35,36), it is clear that random
vesicle lateral movement is not free Brownian motion;
rather, it is confined as if the vesicle were ‘‘caged’’ by certain
physical barriers or tethering interactions. Of interest, vesicle
lateral motion was more severely restricted in the choles-
terol-depleted cells (Movie S2) as compared to the control
cells (Movie S3).FIGURE 5 Cholesterol-stimulated vesicle release re-
vealed by TIRFM. (A) NPY-EGFP-labeled subplasmalem-
mal vesicles are visualized by TIRFM before (top) and
100 s after (bottom) application of 2 mM cholesterol to
the bath solution. The vesicles are highlighted by circles
or squares. The squares indicate vesicles newly arrived
from the cytosol. (B) The total number of visible subplas-
malemmal vesicles decreased over time in the presence
of cholesterol (solid circles; average from six cells),
whereas it remained stable without cholesterol (open
circles; average from five cells). The accumulative number
of newly arrived vesicles was enhanced in the presence of
cholesterol (solid triangles) compared to that without
cholesterol (open triangles).Biophysical Journal 97(5) 1371–1380
1376 Zhang et al.FIGURE 6 Vesicle trafficking and docking is choles-
terol-dependent. (A) The motion trajectories of the subplas-
malemmal vesicles in a control cell (left) and a cell depleted
of cholesterol by 5 mM MbCD (right). The cell contours
are outlined by dashed lines. An example trajectory from
the control cell is illustrated with an expanded scale (the
horizontal and vertical scale bars indicate 200 nm). The
smallest rectangle that just encases all the vesicle footprints
(gray and dashed rectangle) gives the first-order estimation
of the coverage area of vesicle motion. (B and C) The statis-
tics (mean 5 SE) of the vesicle motion area and the
number of subplasmalemmal vesicles in control and differ-
ently treated cells (see text). *p < 0.05, **p < 0.01,
***p < 0.001.The area of the smallest rectangle that just encases all the
vesicle footprints gives a first-order estimation of vesicle
motion coverage, as indicated in Fig. 6 A (middle). In the
cholesterol-depleted cells, the average area of motion
coverage was 0.18 5 0.01 mm2 (466 vesicles in 16 cells),
i.e., only ~31% of that in control cells (0.585 0.03mm2, aver-
aged from 509 vesicles in 10 cells; Fig. 6 B). The analyses
included all ‘‘predocked’’ and newly arrived vesicles. Vesi-
cles also transit vertically between the inner cytosol and the
subplasmalemmal region, such that the vesicles near the
membrane are recycled and replenished. However, the total
vesicle number in the subplasmalemmal region remains stable
(Fig. 5 B, open circles) due to the balance between vesicle
arrival and retrieval. As also revealed by TIRFM, the number
of subplasmalemmal vesicles was significantly smaller in the
MbCD-treated cells than in the control cells (23.65 2.7 vs.
11.95 2.6; Fig. 6 C), indicating that the removal of choles-
terol impaired vesicle tethering and docking. Adding choles-
terol back into the cholesterol-depleted cells restored the
number of subplasmalemmal vesicles (22.85 3.0, 16 choles-
terol-reloaded cells; Fig. 6 C), implying the specificity of the
cholesterol effect. On the other hand, replenishment of
membrane cholesterol was unable to rectify the MbCD effect
on vesicle motion (Fig. 6 B). The motion coverage of the
cholesterol-replenished cells was 0.175 0.01 mm2 (523 vesi-
cles in 16 cells), similar to that in the MbCD treated cells. The
reason for this is unknown, but it could be due to damage to
the cholesterol-protein assemblies, after cholesterol deple-
tion, that cannot be reversed by replacement of cholesterol.
As an alternative to MbCD treatment, the availability of
membrane cholesterol was reduced by sequestration of
cholesterol with filipin (37), which binds specifically to
Biophysical Journal 97(5) 1371–1380membrane cholesterol. The filipin treatment also led to a
significant reduction in the motion area of the vesicles
(0.125 0.01 mm2, 328 vesicles in 17 cells) and the number
of subplasmalemmal vesicles (15.4 5 1.8). Furthermore,
when cholesterol was depleted metabolically (by LPDS
medium), the cells also manifested severely restricted vesicle
motion (0.12 5 0.01 mm2, 286 vesicles in 24 cells) and a
reduced number of subplasmalemmal vesicles (9.5 5 1.3),
similar to the MbCD-treated and filipin-treated cells. The
reduced vesicle motion was not correlated to the change in
the vesicle dwell time. The average vesicle dwell times in
the subplasmalemmal region for the untreated cells, the
MbCD-treated cells, the cholesterol-reloaded cells, the fili-
pin-treated cells, and the cells after metabolic deprivation
of cholesterol were 36.8 5 2.0 s, 25.5 5 1.8 s, 44.3 5
1.9 s, 62.6 5 2.4 s, and 59.9 5 2.6 s, respectively. There-
fore, the reduced motion coverage is due to a reinforced
confinement of vesicle movement imposed by certain choles-
terol-dependent mechanisms.
The similar observations from three different protocols to
decrease the availability of membrane cholesterol corrobo-
rate the notion that membrane cholesterol is critical for
vesicle docking and trafficking. This could also provide an
explanation for the observed effects of cholesterol depletion
on the frequency and fusion kinetics of the exocytotic events.
DISCUSSION
As a key constituent of the cell membranes and a precursor to
steroid hormones, cholesterol is implicated in numerous
structural and functional capacities. Therefore, cholesterol
levels are highly regulated at both body and cellular levels.
Cholesterol to Exocytosis 1377Abnormalities in its homeostasis can lead to various
diseases, such as developmental abnormalities, neurodegen-
erative disease, or hormone disorders (8,38). It is becoming
increasingly clear that cholesterol is critically involved in
membrane fusion and exocytosis (10,16,21). In this study,
we carefully examined and demonstrated the importance of
cholesterol for various aspects of vesicular exocytosis in
PC12 cells by 1), comparing exocytotic responses from the
same cell before and after MbCD-induced cholesterol deple-
tion to avoid the typically large cell-to-cell variation; 2),
addressing concerns about the specificity of MbCD by re-
plenishing cholesterol in the cell membrane and using alter-
native strategies for cholesterol deprivation; 3), analyzing in
detail the effects of cholesterol on quantal vesicle fusion; 4),
performing TIRFM imaging of vesicle docking and traf-
ficking, which is directly related to the exocytotic compe-
tence and dynamics (24); and 5), demonstrating the ability
of exogenous cholesterol to induce vesicle fusion.
Several lines of evidence have suggested the existence
of membrane microdomains enriched with cholesterol
and sphingolipids (39–42). These microdomains are usually
called ‘‘lipid rafts’’ because they exist in a less fluid and
more ordered state than glycerophospholipid-rich domains
of the membrane. Small cholesterol molecules are thought
to intercalate between hydrocarbon chains of sphingolipids,
acting as a dynamic glue to stabilize the raft assembly. The
ability of lipid rafts to concentrate specific proteins and
exclude others makes them ideal functional platforms for
spatially organizing cellular events with high efficiency on
the plasma membrane. In view of the raft theory (42), it is
plausible that a reduction of membrane cholesterol can disrupt
raft structures and change the biological functions mediated
by raft proteins. Cholesterol-rich microdomains have been
proposed to be the sites of vesicle docking and fusion because
proteins such as syntaxin and SNAP-25, which are critically
implicated in exocytosis, have been demonstrated to associate
with these domains (15,43), and cholesterol depletion dissoci-
ates SNAREs from rafts, leading to severe inhibition of
exocytosis (9,16). Our observations that deprivation of
membrane cholesterol by different means significantly
reduced the number of membrane-tethered or -docked vesi-
cles (Fig. 6 C) and the extent of Ca2þ-triggered exocytosis
(Fig. 1) lend further support to this hypothesis.
Depletion of membrane cholesterol led to markedly
reduced lateral motion of the subplasmalemmal vesicles.
This may partly account for the inhibition in exocytosis
caused by cholesterol depletion, because the constant move-
ment of the subplasmalemmal vesicles directly relates to the
dynamics of exocytosis (24,34). Studies have demonstrated
that depletion of membrane cholesterol by MbCD causes
the formation of solid-like membrane domains and conse-
quently impedes the diffusion of membrane proteins and
lipids (44,45). The hindered protein diffusion may be related
to the reduction in vesicle lateral motion, since subplasma-
lemmal vesicles are presumably tethered to the plasmamembrane through a set of membrane-associated proteins
(e.g., SNAREs) and move together with these protein
complexes as a drifting raft. The ability of cholesterol to
facilitate vesicle motion may help vesicles to explore suffi-
ciently near the plasma membrane and become fully assem-
bled to fusion competence. Since vesicle motion depends on
the cortical actin network (46), cholesterol depletion could
exert its effect by modulating actin polymerization (22).
However, fluorescence staining and imaging of the cortical
actin network using TIRFM and confocal imaging did not
show any obvious differences between MbCD-treated and
untreated cells (data not shown). Nonetheless, it is note-
worthy that any possible alterations in the nanostructured
actin meshwork with a size below the diffraction limit
(~150 nm) cannot be resolved by optical imaging.
It has been hypothesized that, before fusion, the outer
leaflet of the vesicle membrane and the inner leaflet of the
plasma membrane merge first while the distal membrane
leaflets remain separated (47). This intermediate hemifusion
structure is delicately stabilized by the proteins and particular
lipid species until the final thrust, probably provided by
twisting of the SNARE complex upon triggering, causes
the formation of a small aqueous fusion pore (~1.5 nm).
Soon after formation, the fusion pore dilates rapidly to
release the vesicular contents. The reduction in exocytosis
by cholesterol depletion may be partly attributable to an inhi-
bition of hemifusion formation, and thus decrease in the
number of releasable vesicles.
In a previous study on PC12 cells (16), it was reported that
cholesterol deprivation by MbCD reduced the extent of
exocytosis but did not affect the quantal release. Here, we
carefully revisited that issue by comparing the exocytotic
events before and after MbCD treatment in the same cell.
We found that depletion of cholesterol caused slower fusion
kinetics and a smaller quantal size (Fig. 2). This is in accor-
dance with the notion that negatively curved cholesterol (48)
facilitates the formation and expansion of the fusion pore.
The percentage and size of the foot signal were reduced by
cholesterol depletion, indicating that the initial opening of
the fusion pore was hindered. It is consistent with the view
that depletion of cholesterol impairs the efficiency of the
Ca2þ-dependent fusion process (10). In addition, vesicles
took a longer time to discharge their contents after choles-
terol depletion (Fig. 3). In particular, the molecular machine
that has been postulated to facilitate the fusion of large vesi-
cles was disabled by cholesterol depletion. The roles of
cholesterol in fusion therefore appear to be threefold, as it
facilitates the formation of hemifusion structure, fusion
pore expansion, and the assembly of the ‘‘additional’’ fusion
machines in large vesicles.
Because the large dense core vesicles in neuroendocrine
cells, and synaptic vesicles in neurons are small (<100 nm)
and their vesicular fusion occurs rapidly (on the millisecond
scale) with involvement of various protein and lipid factors,
it is difficult to identify their hemifusion structure and
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model systems have been utilized to study membrane fusion
and the regulatory roles of cholesterol. Hemifused interme-
diate was identified in artificial liposomes by means of
microspectrofluorometry (49). Garcia et al. (50) found that
cholesterol stabilizes hemifused phospholipid bilayer vesi-
cles. The same study, however, suggested that cholesterol
inhibits transition from hemifusion to full fusion, contradict-
ing our observation that removal of cholesterol slowed the
fusion pore expansion. Homotypic fusion between cortical
vesicles, which possess protein machinery that is critical
for exocytosis and are much larger than large dense core
vesicles and synaptic vesicles, has been used as a reduced
model system for studying vesicular fusion (51,52). Church-
ward et al. (10,53) demonstrated that cholesterol, by virtue of
its intrinsic negative curvature, promotes the formation of a
highly curved fusion intermediate and Ca2þ-triggered fusion
pore formation and expansion. Fusion between cell mem-
branes catalyzed by minimal fusion proteins (viral protein
Hemagglutinin) is instrumental in investigating the roles of
various lipids, such as cholesterol (54). A recent study (21)
based on this technique corroborated the hypothesis that
cholesterol acts during two stages in membrane fusion: be-
fore fusion pore opening and during fusion pore expansion.
It has been theoretically demonstrated that membrane
tension created by adding cholesterol molecules to the exo-
plasmic leaflet of the plasma membrane may provide a direct
driving force to cause full expansion of the hemifusion dia-
phragm (55). It explains our observation that the addition of
free cholesterol to the bath solution triggered vesicle fusion,
albeit with less potency compared to high Kþ stimulation
(Fig. 4 B). Although cholesterol-induced fusion is distinctly
different from native Ca2þ-triggered vesicular fusion, the
results suggest that the semistable hemifusion structure is
in a delicate energetic balance, and the addition of negatively
curved cholesterol favors the transition from hemifusion to
‘‘spontaneous’’ full fusion. Not unexpectedly, cholesterol-
induced quantal release, without the driven force provided
by secretory proteins, manifested a much slower expansion
of the fusion pore and longer fusion time for a given vesicle
size (Fig. 4, C–E). When subjected to the same uniform
driving force (membrane stress introduced by the addition
of cholesterol), t1/2 scales linearly with Q
1/3 for both small
and large vesicles, i.e., larger vesicles take a longer time to
release their contents. The comparison between lipid-driven
fusion and protein-driven fusion may allow us to decipher
the energetic actions provided by the fusion proteins at
different stages of fusion.
Functional studies of membrane cholesterol have relied
mostly on pharmacological agents (b-cyclodextrins, particu-
larly MbCD) as cholesterol acceptors to remove membrane
cholesterol, or cholesterol donors to load cell membranes
with cholesterol. Although this is regarded as the most
popular and effective method to manipulate membrane
cholesterol content, nonspecific effects of cyclodextrin
Biophysical Journal 97(5) 1371–1380have also been reported, and hence one should use caution
when interpreting the data (29). We used different methods
to deplete cholesterol to confirm the specificity of choles-
terol. In addition, we showed that cholesterol depletion did
not affect cell viability (Fig. S2), morphology, or adhesion
(Fig. S3). Furthermore, the replenishment of cholesterol
was able to completely rescue the fusion kinetics (i.e., the
amplitude, rise slope, quantal size, and fusion time) and
vesicle docking. On the other hand, MbCD-induced inhibi-
tion of exocytosis and confinement of vesicle motion could
not be reversed by replenishment of membrane cholesterol.
However, it is unlikely that the observed phenomena resulted
from nonspecific MbCD actions, because additional applica-
tion of cholesterol-loaded MbCD did not cause further
suppression (Figs. 1 and 6). Instead, it is conceivable that
disruptions (e.g., on cholesterol-protein assemblies or
membrane microdomains) caused by cholesterol depletion
that are relevant to vesicle competence and movement
cannot be reversed by simply adding cholesterol back into
the plasma membrane.
In conclusion, the data presented in this study establish
that, in addition to its known effect in maintaining the extent
of exocytosis, cholesterol plays multiple roles in facilitating
exocytosis. The efficiency of exocytosis depends on the
availability of membrane cholesterol, which is important
for maintaining vesicle fusion/docking structures and facili-
tating vesicle trafficking. Cholesterol also ensures the effi-
ciency of quantal vesicle fusion by promoting the formation
of negatively curved fusion structures and by stabilizing
fusion machines.
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